Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) Operating Margin (2023 - 2026)

Camp4 Therapeutics' Operating Margin history spans 3 years, with the latest figure at 3671.26% for Q4 2025.

  • On a quarterly basis, Operating Margin fell 151881.0% to 3671.26% in Q4 2025 year-over-year; TTM through Dec 2025 was 1502.43%, a 663975.0% increase, with the full-year FY2025 number at 1502.43%, up 663990.0% from a year prior.
  • Operating Margin hit 3671.26% in Q4 2025 for Camp4 Therapeutics, down from 1717.11% in the prior quarter.
  • Over the last five years, Operating Margin for CAMP hit a ceiling of 870.27% in Q2 2025 and a floor of 3671.26% in Q4 2025.
  • Historically, Operating Margin has averaged 2243.84% across 3 years, with a median of 1934.78% in 2024.
  • The widest YoY moves for Operating Margin: up -151881bps in 2025, down -151881bps in 2025.
  • Tracing CAMP's Operating Margin over 3 years: stood at 3525.14% in 2023, then surged by 39bps to 2152.45% in 2024, then tumbled by -71bps to 3671.26% in 2025.
  • Business Quant data shows Operating Margin for CAMP at 3671.26% in Q4 2025, 1717.11% in Q3 2025, and 870.27% in Q2 2025.